Double chimeric peptide vaccine feasible for human use that protects against disseminated candidiasis caused by medically important candida species
Ended Project Grant Awarded Last action
- Award ID
- R41AI138722
- Recipient
-
Autoimmune Technologies, LLC UEI NBLGCCAQXG85
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,645
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- New Orleans, LA 70112, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,645 |
Quick answers
Who received award R41AI138722?
R41AI138722 was awarded to Autoimmune Technologies, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 13, 2018.
How much is award R41AI138722 worth?
$224,645 has been obligated on R41AI138722.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award